The following are examples of indicators for monitoring and evaluation (M&E) of demand generation programs for implants. M&E indicators should be developed based on formative research and should indicate whether the key messages and strategies are having the desired effect on the target audience.  In countries and contexts that have national M&E indicators for family planning, demand generation program indicators should align with the national M&E indicators as much as possible.

Illustrative indicators

The following illustrative indicators are examples of useful indicators for measuring project implementation and effects.

Women:

• Number of television spots aired on TV (Monitoring- communication channel statistics)
• Proportion of women of reproductive age who believe that implants are a healthy and acceptable option for family planning. (Evaluation- omnibus survey or nationally representative survey)
• Number of implants inserted following demand generation campaign (Evaluation- service statistics)
• Proportion of family planning users using the implant (Evaluation- DHS or nationally representative survey)
• Proportion of women of reproductive age who report that they talked to their spouse about family planning options, including the implant (Evaluation- omnibus survey or nationally representative survey)
• Proportion of women of reproductive age who report that they know where to access information and services for implants (Evaluation- omnibus survey or nationally representative survey)

Providers:

• Number of clinical providers who viewed training video on appropriate contraceptive counseling (Monitoring- communication channel statistics)
• Number of households visited by non-clinical providers (Monitoring- provider self-reported data)
• Number of referrals made by non-clinical providers using counseling cards (Monitoring- provider self reported data)
• Proportion non clinical and clinical providers who can accurately report the eligibility criteria for different contraceptive methods (Evaluation- provider self reported data or survey)
• Proportion of clinical providers who report that they have high self-efficacy for provision of implants (Evaluation- provider self reported data or survey)

Partners:

• Number of partners of women of reproductive age who reported viewing TV spots related to family planning and the implant (Monitoring- nationally representative surveys)
• Proportion of partners of women of reproductive age who report that the implant is a healthy and acceptable option for family planning (Evaluation- omnibus surveys or nationally representative surveys)
• Proportion of partners of women of reproductive age who report that they talked to their spouse about family planning options, including the implant (Evaluation- omnibus surveys or nationally representative surveys)